Inventor · disambiguated record
Tillman U. Gerngross
Also filed as: GERNGROSS TILLMAN · GERNGROSS TILLMAN U · GERNGROSS TILLMAN ULF
34 granted patents·24 pending applications·1,772 citations·filing 1994–2023
98Inventor score
Top patents by PatentIndex Score
58 records- 0199US6245537B1Removing endotoxin with an oxdizing agent from polyhydroxyalkanoates produced by fermentationMETABOLIX INC·Filed 1998·Granted Jun 12, 2001·328 cites·13 claims
- 0298US8691730B2Rationally designed, synthetic antibody libraries and uses thereforVASQUEZ MAXIMILIANO·Filed 2008·Granted Apr 8, 2014·73 cites·15 claims
- 0398US7449308B2Combinatorial DNA library for producing modified N-glycans in lower eukaryotesGLYCOFI INC·Filed 2003·Granted Nov 11, 2008·138 cites·41 claims
- 0498US7326681B2Methods for producing modified glycoproteinsGLYCOFI INC·Filed 2005·Granted Feb 5, 2008·150 cites·32 claims
- 0598US7244442B2Method for making devices using polyhydroxyalkanoate having pyrogen removedMETABOLIX INC·Filed 2003·Granted Jul 17, 2007·109 cites·24 claims
- 0698US7029872B2Methods for producing modified glycoproteinsGLYCOFI INC·Filed 2001·Granted Apr 18, 2006·308 cites·30 claims
- 0797US7629163B2Methods for producing modified glycoproteinsGLYCOFI INC·Filed 2005·Granted Dec 8, 2009·49 cites·37 claims
- 0897US6623749B2Medical device containing polyhydroxyalkanoate treated with oxidizing agent to remove endotoxinMETABOLIX INC·Filed 2001·Granted Sep 23, 2003·107 cites·17 claims
- 0996US8231889B2Method of forming medical devices having pyrogen removed for in vivo applicationWILLIAMS SIMON F·Filed 2011·Granted Jul 31, 2012·52 cites·21 claims
- 1095US8877688B2Rationally designed, synthetic antibody libraries and uses thereforVASQUEZ MAXIMILIANO·Filed 2009·Granted Nov 4, 2014·27 cites·8 claims
- 1195US7795002B2Production of galactosylated glycoproteins in lower eukaryotesGLYCOFI INC·Filed 2005·Granted Sep 14, 2010·29 cites·36 claims
- 1294US8883483B2Combinatorial DNA library for producing modified N-glycans in lower eukaryotesGERNGROSS TILLMAN U·Filed 2011·Granted Nov 11, 2014·15 cites·19 claims
- 1394US8445227B2N-acetylglucosaminyltransferase III expression in lower eukaryotesBOBROWICZ PIOTR·Filed 2009·Granted May 21, 2013·23 cites·9 claims
- 1494US7598055B2N-acetylglucosaminyltransferase III expression in lower eukaryotesGLYCOFI INC·Filed 2003·Granted Oct 6, 2009·41 cites·22 claims
- 1593US8877462B2Combinatorial DNA library for producing modified N-glycans in lower eukaryotesGERNGROSS TILLMAN U·Filed 2012·Granted Nov 4, 2014·10 cites·18 claims
- 1693US8067551B2Combinatorial DNA library for producing modified N-glycans in lower eukaryotesGERNGROSS TILLMAN U·Filed 2008·Granted Nov 29, 2011·12 cites·17 claims
- 1793US7479389B2ARG1, ARG2, ARG3, HIS1, HIS2, HIS5, HIS6 genes and methods for stable genetic integrationGLYCOFI INC·Filed 2005·Granted Jan 20, 2009·20 cites·5 claims
- 1892US8211691B2Methods for producing modified glycoproteinsGERNGROSS TILLMAN U·Filed 2007·Granted Jul 3, 2012·13 cites·25 claims
- 1992US7923430B2Methods for producing modified glycoproteinsGLYCOFI INC·Filed 2005·Granted Apr 12, 2011·13 cites·16 claims
- 2091US8771720B2Medical device comprising polyhydroxyalkanoate having pyrogen removed using oxidizing agentWILLIAMS SIMON F·Filed 2012·Granted Jul 8, 2014·13 cites·16 claims
- 2191US5480794AOverproduction and purification of soluble PHA synthaseMASSACHUSETTS INST TECHNOLOGY·Filed 1994·Granted Jan 2, 1996·154 cites·23 claims
- 2289US10189894B2Rationally designed, synthetic antibody libraries and uses thereforADIMAB LLC·Filed 2014·Granted Jan 29, 2019·6 cites·7 claims
- 2389US7981660B2Methods for producing modified glycoproteinsGLYCOFI INC·Filed 2009·Granted Jul 19, 2011·6 cites·21 claims
- 2488US7935513B2Combinatorial DNA library for producing modified N-glycans in lower eukaryotesGLYCOFI INC·Filed 2008·Granted May 3, 2011·5 cites·17 claims
- 2587US7906135B2Medical device comprising polyhydroxyalkanoate having pyrogen removedMETABOLIX INC·Filed 2007·Granted Mar 15, 2011·6 cites·18 claims
- 2686US10196635B2Rationally designed, synthetic antibody libraries and uses thereforADIMAB LLC·Filed 2014·Granted Feb 5, 2019·4 cites·7 claims
- 2786US8697394B2Production of modified glycoproteins having multiple antennary structuresBOBROWICZ PIOTR·Filed 2004·Granted Apr 15, 2014·11 cites·21 claims
- 2886US6228934B1Methods and apparatus for the production of amorphous polymer suspensionsMETS OLIX INC·Filed 1999·Granted May 8, 2001·38 cites·13 claims
- 2985US8815544B2Production of galactosylated glycoproteins in lower eukaryotesDAVIDSON ROBERT·Filed 2010·Granted Aug 26, 2014·4 cites·14 claims
- 3083US2023399386A1Rationally designed, synthetic antibody libraries and uses thereforADIMAB LLC·Filed 2023·Application pending·0 cites
- 3181US11008383B2Rationally designed, synthetic antibody libraries and uses thereforADIMAB LLC·Filed 2018·Granted May 18, 2021·1 cites·19 claims
- 3280US11008568B2Rationally designed, synthetic antibody libraries and uses thereforADIMAB LLC·Filed 2018·Granted May 18, 2021·1 cites·17 claims
- 3369US2015051381A1Combinatorial dna library for producing modified n-glycans in lower eukaryotesGLYCOFI INC·Filed 2014·Application pending·0 cites
- 3468US2014234902A1Methods for producing modified glycoproteinsGLYCOFI INC·Filed 2014·Application pending·0 cites
- 3567US6323276B2Methods and apparatus for the production of amorphous polymer suspensionsMETABOLIX INC·Filed 2001·Granted Nov 27, 2001·5 cites·6 claims
- 3666US2013295604A1Methods for producing modified glycoproteinsGERNGROSS TILLMAN U·Filed 2013·Application pending·0 cites
- 3765US2009226959A1Production of modified glycoproteins having multiple antennary structuresBOBROWICZ PIOTR·Filed 2008·Application pending·0 cites
- 3864US2015079633A1Production of modified glycoproteins having multiple antennary structuresGLYCOFI INC·Filed 2014·Application pending·0 cites
- 3963US2016068880A1Methods for producing modified glycoproteinsGLYCOFI INC·Filed 2015·Application pending·0 cites
- 4063US2012322100A1Methods for producing modified glycoproteinsGERNGROSS TILLMAN U·Filed 2012·Application pending·0 cites
- 4162US2007178551A1Methods for producing modified glycoproteinsGLYCOFI INC·Filed 2005·Application pending·0 cites
- 4260US2011020870A1Methods for producing modified glycoproteinsGLYCOFI INC·Filed 2010·Application pending·0 cites
- 4356US2009162377A1Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoformGERNGROSS TILLMAN U·Filed 2008·Application pending·0 cites
- 4455US2010184143A1Immunoglobulins comprising predominantly a Man3GlcNAc2 glycoformGERNGROSS TILLMAN U·Filed 2008·Application pending·0 cites
- 4552US6605262B2Methods and apparatus for the production of amorphous polymer suspensionsMETABOLIX INC·Filed 2001·Granted Aug 12, 2003·1 cites·3 claims
- 4648US2006024292A1Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoformGERNGROSS TILLMAN U·Filed 2005·Application pending·0 cites
- 4747US2006034829A1Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoformGERNGROSS TILLMAN U·Filed 2005·Application pending·0 cites
- 4845US2006252096A1Single chain antibody with cleavable linkerGLYCOFI INC·Filed 2006·Application pending·0 cites
- 4941US2006257399A1Immunoglobulins comprising predominantly a Man5GIcNAc2 glycoformGLYCOFI INC·Filed 2005·Application pending·0 cites
- 5041US2009136525A1Immunoglobulins Comprising Predominantly a Glcnacman3Glcnac2 GlycoformGERNGROSS TILLMAN·Filed 2006·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →